Previous 10 | Next 10 |
Source: GraycellAdvisors.com Systematic Investing Systematic investing has become a growing part of the stock market. The investing style refers to a rules-based algorithmic system that limits or eliminates individual judgments and biases towards portfolio selection and adjustments. ...
Axonics Modulation Technologies, Inc. (NASDAQ:AXNX), a medical technology company that has developed and is commercializing novel implantable rechargeable Sacral Neuromodulation (SNM) devices for the treatment of bladder and bowel dysfunction, today announced U.S. Food & Drug Administrati...
After management offered an early look at the company's fourth-quarter financial results, Axonics Modulation Technologies (NASDAQ: AXNX) shares are rocketing 24.5% higher at 1:00 p.m. EST on Thursday. Axonics secured Food and Drug Administration approval to begin marketing its implantable t...
Gainers: Trillium Therapeutics (NASDAQ: TRIL ) +106% . More news on: Trillium Therapeutics Inc., Applied Genetic Technologies Corporation, Genetic Technologies Limited, Stocks on the move, Read more ...
Applied Genetic Technologies (NASDAQ: AGTC ) +53% on positive XLRP data . More news on: Applied Genetic Technologies Corporation, VBI Vaccines Inc., The Peck Company Holdings, Inc., Stocks on the move, Read more ...
Axonics Modulation Technologies (NASDAQ: AXNX ) has reported preliminary Q4 and FY 2019 revenue. More news on: Axonics Modulation Technologies, Inc., Healthcare stocks news, Read more ...
Axonics Modulation Technologies, Inc. (NASDAQ: AXNX), a medical technology company that has developed and is commercializing novel implantable rechargeable Sacral Neuromodulation (“SNM”) devices for the treatment of urinary and bowel dysfunction, today reported preliminary unaud...
Agilent (NYSE: A ) initiated with Overweight rating and $100 (18% upside) price target at Wells Fargo. More news on: Agilent Technologies, Inc., Avantor, Inc., Axonics Modulation Technologies, Inc., Healthcare stocks news, Stocks on the move, , Read more ...
The USPTO has issued or allowed Axonics Modulation Technologies (NASDAQ: AXNX ) nine U.S. utility patents in 2019, along with numerous foreign counterparts relating to its implantable sacral neuromodulation technology. More news on: Axonics Modulation Technologies, Inc., Healthcare stock...
Seven Additional Patents Granted in Western Europe, Japan, China, Australia and Canada Axonics Modulation Technologies, Inc. (NASDAQ: AXNX), a medical technology company that has developed and is commercializing novel implantable Sacral Neuromodulation (“SNM”) devices for...
News, Short Squeeze, Breakout and More Instantly...
Axonics Modulation Technologies Inc. Company Name:
AXNX Stock Symbol:
NASDAQ Market:
Axonics Modulation Technologies Inc. Website:
Axonics, Inc. (NASDAQ: AXNX) has caught the attention of the investment community today with its bullish price action. The company's shares have moved 0.09% on the day to $68.5. Axonics, Inc., a medical technology company, engages in the development and commercialization of sacral neuromodulat...
Generated record revenue, gross margin and net income in 2Q24 Axonics, Inc. (Nasdaq: AXNX), a medical technology company that develops, manufactures and commercializes innovative and minimally invasive products to treat bladder and bowel dysfunction, today reported financial results f...
Viridien ADR (CGGYD) is expected to report for Q2 2024 Civitas Resources Inc. (CIVI) is expected to report $2.9 for Q2 2024 Aptiv PLC (APTV) is expected to report $1.37 for Q2 2024 Ardelyx Inc. (ARDX) is expected to report $-0.1 for Q2 2024 Beazer Homes USA Inc. (BZH) is expected ...